Conference Coverage
Conference Coverage
Lessons learned from the PCSK9 inhibitor trials
LOS ANGELES – The higher your risk, the greater your benefit from therapeutic intervention.
Conference Coverage
SGLT-2 inhibitors promising for heart failure prevention, not treatment
LOS ANGELES – The combination of heart failure and diabetes is particularly lethal.
Conference Coverage
Does reduced degradation of insulin by the liver cause type 2 diabetes?
LOS ANGELES – Hepatic insulin clearance is significantly lower in African Americans, compared with European Americans, a difference that may...
Conference Coverage
‘Payoff will be great’ if we can conquer childhood obesity, expert says
LOS ANGELES – Direct evidence of a link between obesity in youth and adult cardiovascular disease is beginning to emerge.
Conference Coverage
Real-world weight loss with meds approximates RCT results
NASHVILLE, TENN. – The real-world study saw more adverse events – but no attrition from side effects.
Conference Coverage
For weight-loss apps, the evidence base is still small
NASHVILLE – The most effective apps took advantage of gamification and other uniquely digital features.
Conference Coverage
Heavy drinkers have a harder time keeping the weight off
NASHVILLE – Teetotalers had the best luck maintaining weight loss, but the differences were small.
Conference Coverage
Study investigates statin-diabetes link
Complete results are expected by the end of 2019.
Conference Coverage
Should metabolic syndrome be renamed circadian syndrome?
Cluster of conditions “is now the main driver of the global chronic disease epidemic and its health burden,” expert says.
Conference Coverage
Diuretics linked to diabetic amputations in T2DM
BERLIN – An increase in lower extremity amputations was seen among patients with type 2 diabetes mellitus who were treated with diuretics.